Guest Contributor

Pharmaceutical R&D spending registers first decline since late 1980s: PMPRB

Guest Contributor
November 9, 2004

R&D spending by Canada’s pharmaceutical industry declined in 2003 after 14 consecutive years of increases and dipped below the critical 10% R&D-to-sales ratio. The 2003 ratio for all patentees is 8.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

Ontario set to unveil major new research and commercialization strategy

Public funds target innovative features of new Ford flexible manufacturing facility

Canadian universities enjoy another strong year for sponsored research income

$12-billion spending review could alter Canada’s science priorities for next 5 years






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.